Becton Dickinson and Company
Becton Dickinson and Company/ US0758871091 /
BDX
|
14/06/2024 22:10:00
|
Diferencia
+1.76
|
Volumen |
Bid2:00:00 |
Ask2:00:00 |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
|
233.73USD
|
+0.76%
|
1.05 millones
Volumen de negocios: 116.14 millones |
230.17Volumen de oferta: 100 |
240.19Tamaño/ Volumen/ Formato de Ask: 200 |
67.55 mil millonesUSD |
1.56% |
47.03 |
Descripción de negocio
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. The innovative solutions are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; advancing cellular research and applications; enhancing the diagnosis of infectious diseases and cancers; and supporting the management of diabetes.
Consejo de gestión & Consejo de supervisión
| CEO |
| Tom Polen |
| Consejo de gestión |
| Christopher DelOrefice, Ami Simunovich, Dave Hickey, David Shan, Elizabeth McCombs, Roland Goette, William R. Sigmund, II, Michelle Quinn, Shana Neal, Pavan Mocherla, Vishy Kanda, Michael Garrison, Denise Fleming, Tony Ezell, Richard Byrd, Herman Cueto, Jeff Silvestri |
| Consejo de supervisión |
| Tom Polen, Bertram L. Scott, Timothy M. Ring, Marshall O. Larsen, Christopher Jones, Jeffrey W. Henderson, Claire M. Fraser, R. Andrew Eckert, Carrie Byington, Catherine M. Burzik, William M. Brown, Joanne Waldstreicher |
Datos de la empresa
| Nombre: |
Becton, Dickinson and Company |
| Dirección: |
1 Becton Drive,Franklin Lakes, New Jersey 07414, USA |
| Teléfono: |
+1-201-847-6800 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
www.bd.com |
| Industria: |
Healthcare |
| Sector: |
Medical Products |
| Subsector: |
Advanced Medical Devices |
| Fin del año financiero: |
30/09 |
| Acciones de libre circulación: |
77.40% |
| Fecha de OPI: |
23/04/1962 |
